Wuhan Keqian Biology Co Ltd
SSE:688526
Wuhan Keqian Biology Co Ltd
SSE:688526
Price:
16.18
CNY
1.25%
Market Closed
Market Cap:
¥7.5B
Relative Value
The Relative Value of one
Wuhan Keqian Biology Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 16.18 CNY,
Wuhan Keqian Biology Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Wuhan Keqian Biology Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Wuhan Keqian Biology Co Ltd Competitors
Wuhan Keqian Biology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Wuhan Keqian Biology Co Ltd
SSE:688526
|
7.5B CNY | 7.4 | 16.4 | 14.3 | 14.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD | 17.5 | 56.5 | 37.8 | 40.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
560.6B USD | 6 | 21 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
287.9B CHF | 4.7 | 30.7 | 12.9 | 15.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.3B GBP | 5.1 | 31.6 | 15.1 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.3B USD | 4.6 | 15.6 | 11 | 13 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.6B CHF | 5.3 | 20.5 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.3 | 13.1 | 9.2 | 10.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
148.6B USD | 2.4 | 15.3 | 7.7 | 10.6 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR | 1.8 | 8.3 | 7.8 | 7.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
